Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $28.5 Million - $32.1 Million
-148,700 Reduced 19.53%
612,700 $130 Million
Q2 2023

Aug 11, 2023

BUY
$187.64 - $206.25 $77.7 Million - $85.4 Million
414,000 Added 119.17%
761,400 $147 Million
Q1 2023

May 16, 2023

BUY
$127.59 - $203.08 $31.8 Million - $50.7 Million
249,500 Added 254.85%
347,400 $70.3 Million
Q4 2022

Feb 14, 2023

SELL
$117.37 - $139.17 $36.7 Million - $43.6 Million
-313,100 Reduced 76.18%
97,900 $12.6 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $39.7 Million - $52.9 Million
293,800 Added 250.68%
411,000 $56.2 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.